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Introduction
Clostridium difficile (CD) is one of the most common
nosocomial infections in the United States. Rapid identifi-
cation and isolation of hospitalized patients with CD colo-
nization or infection is critical to preventing transmission.
Objectives
This work assesses the potential impact of an active sur-
veillance (AS) strategy for CD via admission testing on
overall costs and infections.
Methods
We designed an agent-based simulation of nosocomial CD
transmission with static and dynamic components includ-
ing: patients, healthcare workers (HCW), and rooms;
patient admission, discharge, and transfer; interactions
between HCW and patients; contamination of rooms by
patients shedding CD; HCW hand carriage and removal
via hand hygiene or prevention via personal protective
equipment; and patient acquisition of CD following con-
tact with contaminated rooms or HCW. Model para-
meters were derived from local data, literature where
available, and expert opinion. The model was calibrated
against local data and validated internally and externally.
Two scenarios with varying CD importation prevalence
were simulated 60 times each over a one-year period. One
scenario reflected the usual strategy of no admission test-
ing, while another reflected an AS strategy with CD testing
of all patients upon admission. Importation prevalence was
varied in a sensitivity analysis from 0%>30%. Cost input
parameters were obtained from the literature.
Results
At moderate to high levels of CD importation (≥9%) an
AS strategy is cost-saving overall, reducing costs by
between $10 and $20 per patient, owing primarily to
CD infections prevented. The cost savings plateaued at
an importation prevalence above 12%. At low CD
importation (<6%), the AS strategy costs more than no
surveillance, though costs per patient are low. Up to
38 CD infections per 10,000 patient-days could be
prevented with an AS strategy.
Conclusion
Despite the additional cost of testing and isolation, an
inpatient AS strategy for CD may be cost-saving through
the prevention of CD transmissions and infections. Given
reported CD admission prevalence and infection mortality
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